Suchergebnisse - "Russo, Alessandro"

PubPharm (27)

1

LIBRETTO-431 : Is it time to reconsider randomized phase 3 trials for uncommon oncogenic drivers in non-small-cell lung cancer?

enthalten in: Med (New York, N.Y.) | 2024

von Russo, A. | Muscolino, P. | Rolfo, C.

2

Tracking Clonal Evolution of EGFR-Mutated Non-Small Cell Lung Cancer Through Liquid Biopsy : Management of C797S Acquired Mutation

enthalten in: Clinical lung cancer | 2023

von Russo, A. | Scilla, K. | Mehra, R. | +7

3

Empower the Potential of Trastuzumab Deruxtecan with Novel Combinations

enthalten in: Clinical cancer research : an official journal of the American Association for Cancer Research | 2023

von Rolfo, C. | Del Re, M. | Russo, A.

CommentOn: Clin Cancer Res. 2023 Nov 1;29(21):4385-4398. - PMID 37279095

4

New options and open issues in the management of unresectable stage III and in early-stage NSCLC : A report from an expert panel of Italian medical and radiation oncologists - INTERACTION group

enthalten in: Critical reviews in oncology/hematology | 2023

von Catania, C. | Filippi, A. | Sangalli, C. | +13

5

Exploiting the Full Potential of Novel Agents Targeting EGFR Exon 20 Insertions in Advanced NSCLC : Next-Generation Sequencing Outperforms Polymerase Chain Reaction-Based Testing

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Rolfo, C. | Russo, A.

CommentOn: J Thorac Oncol. 2023 Jun;18(6):744-754. - PMID 36738930

6

RET-MAP : An International Multicenter Study on Clinicobiologic Features and Treatment Response in Patients With Lung Cancer Harboring a RET Fusion

enthalten in: Journal of thoracic oncology : official publication of the International Association for the Study of Lung Cancer | 2023

von Aldea, M. | Marinello, A. | Duruisseaux, M. | +42

CommentIn: J Thorac Oncol. 2023 May;18(5):549-551. - PMID 37087114

7

Genomic Landscape of Primary Resistance to Osimertinib Among Hispanic Patients with EGFR-Mutant Non-Small Cell Lung Cancer (NSCLC) : Results of an Observational Longitudinal Cohort Study

enthalten in: Targeted oncology | 2023

von Chamorro, D. | Cardona, A. | Rodríguez, J. | +35

8

Skipping or Not Skipping? That's the Question! An Algorithm to Classify Novel MET Exon 14 Variants in Non-Small-Cell Lung Cancer

enthalten in: JCO precision oncology | 2023

von Rolfo, C. | Malapelle, U. | Russo, A.

CommentOn: JCO Precis Oncol. 2023 Feb;7:e2200482. - PMID 36848606

9

Mechanisms of Resistance to First-Line Osimertinib in Hispanic Patients With EGFR Mutant Non-Small Cell Lung Cancer (FRESTON-CLICaP)

enthalten in: Clinical lung cancer | 2022

von Cardona, A. | Ruiz-Patiño, A. | Recondo, G. | +36

10

NTRK1 Fusions identified by non-invasive plasma next-generation sequencing (NGS) across 9 cancer types

enthalten in: British journal of cancer | 2022

von Rolfo, C. | Drilon, A. | Hong, D. | +22